These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35568882)

  • 1. Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis.
    Hur SK; Hunter M; Dominique MA; Farag M; Cotton-Samuel D; Khan T; Trojanowski JQ; Spiller KJ; Lee VM
    Acta Neuropathol Commun; 2022 May; 10(1):75. PubMed ID: 35568882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy.
    Spiller KJ; Cheung CJ; Restrepo CR; Kwong LK; Stieber AM; Trojanowski JQ; Lee VM
    J Neurosci; 2016 Jul; 36(29):7707-17. PubMed ID: 27445147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of motor neuron disease is accelerated and the ability to recover is compromised with advanced age in rNLS8 mice.
    Spiller KJ; Restrepo CR; Khan T; Stieber AM; Kwong LK; Trojanowski JQ; Lee VM
    Acta Neuropathol Commun; 2016 Sep; 4(1):105. PubMed ID: 27687289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of matrix metalloproteinase 9 (MMP-9) protects motor neurons from TDP-43-triggered death in rNLS8 mice.
    Spiller KJ; Khan T; Dominique MA; Restrepo CR; Cotton-Samuel D; Levitan M; Jafar-Nejad P; Zhang B; Soriano A; Rigo F; Trojanowski JQ; Lee VM
    Neurobiol Dis; 2019 Apr; 124():133-140. PubMed ID: 30458231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-23a suppression accelerates functional decline in the rNLS8 mouse model of TDP-43 proteinopathy.
    Tsitkanou S; Della Gatta PA; Abbott G; Wallace MA; Lindsay A; Gerlinger-Romero F; Walker AK; Foletta VC; Russell AP
    Neurobiol Dis; 2022 Jan; 162():105559. PubMed ID: 34774794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Motor neuron translatome reveals deregulation of SYNGR4 and PLEKHB1 in mutant TDP-43 amyotrophic lateral sclerosis models.
    Marques RF; Engler JB; Küchler K; Jones RA; Lingner T; Salinas G; Gillingwater TH; Friese MA; Duncan KE
    Hum Mol Genet; 2020 Sep; 29(16):2647-2661. PubMed ID: 32686835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microglial transcriptome analysis in the rNLS8 mouse model of TDP-43 proteinopathy reveals discrete expression profiles associated with neurodegenerative progression and recovery.
    Hunter M; Spiller KJ; Dominique MA; Xu H; Hunter FW; Fang TC; Canter RG; Roberts CJ; Ransohoff RM; Trojanowski JQ; Lee VM
    Acta Neuropathol Commun; 2021 Aug; 9(1):140. PubMed ID: 34412701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosis.
    Wright AL; Della Gatta PA; Le S; Berning BA; Mehta P; Jacobs KR; Gul H; San Gil R; Hedl TJ; Riddell WR; Watson O; Keating SS; Venturato J; Chung RS; Atkin JD; Lee A; Shi B; Blizzard CA; Morsch M; Walker AK
    Eur J Neurosci; 2021 Sep; 54(6):6237-6255. PubMed ID: 34390052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
    Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglia-mediated recovery from ALS-relevant motor neuron degeneration in a mouse model of TDP-43 proteinopathy.
    Spiller KJ; Restrepo CR; Khan T; Dominique MA; Fang TC; Canter RG; Roberts CJ; Miller KR; Ransohoff RM; Trojanowski JQ; Lee VM
    Nat Neurosci; 2018 Mar; 21(3):329-340. PubMed ID: 29463850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.
    Alhindi A; Shand M; Smith HL; Leite AS; Huang YT; van der Hoorn D; Ridgway Z; Faller KME; Jones RA; Gillingwater TH; Chaytow H
    Neuropathol Appl Neurobiol; 2023 Aug; 49(4):e12925. PubMed ID: 37465879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative features of sporadic amyotrophic lateral sclerosis: Motor neurons of Onuf's nucleus survive in ADAR2-conditional knockout mice.
    Hideyama T; Teramoto S; Kato H; Terashi H; Kwak S; Aizawa H
    J Neurol Sci; 2024 Aug; 463():123142. PubMed ID: 39053342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis.
    Nijssen J; Comley LH; Hedlund E
    Acta Neuropathol; 2017 Jun; 133(6):863-885. PubMed ID: 28409282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withania somnifera Reverses Transactive Response DNA Binding Protein 43 Proteinopathy in a Mouse Model of Amyotrophic Lateral Sclerosis/Frontotemporal Lobar Degeneration.
    Dutta K; Patel P; Rahimian R; Phaneuf D; Julien JP
    Neurotherapeutics; 2017 Apr; 14(2):447-462. PubMed ID: 27928708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperexcitability precedes CA3 hippocampal neurodegeneration in a dox-regulatable TDP-43 mouse model of ALS-FTD.
    Rodemer W; Ra I; Jia E; Gujral J; Zhang B; Hoxha K; Xing B; Mehta S; Farag M; Porta S; Jensen FE; Talos DM; Lee VM
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crush injury to motor nerves in the G93A transgenic mouse model of amyotrophic lateral sclerosis promotes muscle reinnervation and survival of functionally intact nerve-muscle contacts.
    Sharp PS; Tyreman N; Jones KE; Gordon T
    Neurobiol Dis; 2018 May; 113():33-44. PubMed ID: 29409912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.
    Tremblay E; Martineau É; Robitaille R
    J Neurosci; 2017 Sep; 37(37):8901-8918. PubMed ID: 28821658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human TDP-43 and FUS selectively affect motor neuron maturation and survival in a murine cell model of ALS by non-cell-autonomous mechanisms.
    Wächter N; Storch A; Hermann A
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 16(7-8):431-41. PubMed ID: 26174443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
    Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
    Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Size-dependent dendritic maladaptations of hypoglossal motor neurons in SOD1
    Fogarty MJ; Mu EWH; Lavidis NA; Noakes PG; Bellingham MC
    Anat Rec (Hoboken); 2021 Jul; 304(7):1562-1581. PubMed ID: 33099869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.